Estimating the effect size of the 15Q11.2 BP1–BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice

@BGGCardiff @JFGUnderwood @DrKKendall @GeorgeKirov1 Great to see more in-depth phenotypic descriptions of "common" CNVs that are "‘pathogenic of mild effect size". e.g. see https://t.co/kTkYD33uI9. These are some of the most difficult to counsel patients o

Estimating the effect size of the 15Q11.2 BP1–BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice https://t.co/NEHYyGxOBK #neurodevelopment https://t.co/ns3LNlI0jW

Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice. - PubMed - NCBI https://t.co/EoNh2FJkjY